Advanced management of canine cognitive dysfunction syndrome (CDS) in 2026 integrates pharmaceutical treatment, dietary support, environmental enrichment, and owner education to maximise quality of life.
Advanced CDS management in 2026 goes beyond symptom management to multi-modal approaches that slow cognitive decline and maintain quality of life. Pharmaceutical treatment combined with enrichment, dietary support, and environmental modifications delivers better outcomes than any single intervention. Addressing night-time disturbance with appropriate medication significantly improves welfare for both dogs and their owners.